EverHint – SMA20 × SMA50 Crossover Signals for Jan 13, 2026 – Healthcare Leads with 8 Setups
What This Signal Is (Quick)
This strategy detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50):
-
Buy Signal (SMA20_x_SMA50_Buy) - "Golden Cross": SMA(20) crosses above SMA(50) on today's close
- Short-term momentum (20 days) exceeds medium-term trend (50 days)
- Bullish trend confirmation with high reliability
- Ideal for medium-term trend following (4-12 week holding periods)
-
Sell Signal (SMA20_x_SMA50_Sell) - "Death Cross": SMA(20) crosses below SMA(50) on today's close
- Short-term momentum weakens below medium-term trend
- Bearish trend confirmation
- Can signal exit points or trend reversal alerts
Key Characteristics:
- Uses two SMAs (both simple moving averages) for maximum stability
- Most stable strategy - fewer signals but highest quality (fewer whipsaws)
- Better suited for medium-term trends with confirmed momentum
- Lower risk entries compared to faster EMA-based strategies
Key Criteria:
-
Buy: SMA20 crosses above SMA50
-
Sell: SMA20 crosses below SMA50
-
Minimum ADV: $40M (liquidity filter)
-
Earnings buffer: 7 days pre/post earnings
-
Fresh crossover: Detected on today's close
Holding Period: 2-6 weeks
Risk Level: Medium
How We Ranked Today
Ranked by RSI (lower RSI = more oversold for buy signals)
📊 SMA20 × SMA50 Crossover Signals (Top 15 of 32 total)
Ranked by rsi14:
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FSLR | First Solar, Inc. | Technology | 241.36 | 26.6 | $-1.5M | 42 | $37.02 | 25.9 |
| 2 | BR | Broadridge Financial S... | Technology | 221.21 | 33.7 | — | 17 | $13.00 | 25.9 |
| 3 | VTR | Ventas, Inc. | Real Estate | 76.93 | 34.8 | $-25.2M | 29 | $1.47 | 34.0 |
| 4 | BXSL | Blackstone Secured Len... | Financial Services | 25.80 | 36.9 | — | 43 | $2.71 | 6.0 |
| 5 | MTN | Vail Resorts, Inc. | Consumer Cyclical | 141.60 | 40.0 | — | 55 | $8.73 | 5.2 |
| 6 | SMMT | Summit Therapeutics Inc. | Healthcare | 16.81 | 40.1 | $+11.0M | 41 | $1.26 | 12.5 |
| 7 | MDT | Medtronic plc. | Healthcare | 96.42 | 44.0 | — | 35 | $7.60 | 123.7 |
| 8 | LPLA | LPL Financial Holdings... | Financial Services | 364.41 | 45.5 | $-117K | 16 | $43.64 | 29.2 |
| 9 | NOK | Nokia Corporation Spon... | Technology | 6.52 | 49.1 | — | 16 | $0.39 | 35.2 |
| 10 | SNAP | Snap Inc. | Communication Services | 7.99 | 51.2 | $-40.9M | 21 | $0.11 | 13.5 |
| 11 | GTES | Gates Industrial Corpo... | Industrials | 22.41 | 53.8 | — | 23 | $1.95 | 5.7 |
| 12 | FANG | Diamondback Energy, Inc. | Energy | 151.21 | 54.1 | — | 41 | $18.22 | 44.0 |
| 13 | HLI | Houlihan Lokey, Inc. | Financial Services | 180.57 | 54.9 | — | 14 | $9.89 | 12.7 |
| 14 | ADPT | Adaptive Biotechnologi... | Healthcare | 18.07 | 55.4 | $-20.6M | 28 | $-0.19 | 2.8 |
| 15 | MPWR | Monolithic Power Syste... | Technology | 983.28 | 58.4 | $-2.6M | 23 | $34.00 | 47.1 |
Field Notes
Sector concentration: Healthcare (8), Industrials (5), Technology (5)
Insider selling: ADPT (Adaptive Biotechnologies Corpor, $-20.6M), SNAP (Snap Inc., $-40.9M), MPWR (Monolithic Power Systems, Inc., $-2.6M)
Insider buying: FMC (FMC Corporation, $+232K), SMMT (Summit Therapeutics Inc., $+11.0M)
Data coverage: 34.4% insider, 100.0% earnings, 100.0% analyst, 31.2% news
Recent Headlines
ADPT (Adaptive Biotechnologies Corpor)
- Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript (source)
- Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results (source)
- Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $164,400.00 in Stock (source)
- Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock (source)
HLI (Houlihan Lokey, Inc.)
- Houlihan Lokey, Inc. (NYSE:HLI) Given Average Recommendation of “Moderate Buy” by Brokerages (source)
- Houlihan Lokey (NYSE:HLI) General Counsel Christopher Crain Sells 500 Shares of Stock (source)
LPLA (LPL Financial Holdings Inc.)
- Wealth Management Leaders Suzanne Elovic and Mike Murphy Join LPL Financial to Strengthen Advisor and Client Service (source)
- LPL Financial Appoints Ilan Davidovici as Executive Vice President, Corporate Strategy (source)
- Robeco Institutional Asset Management B.V. Increases Stock Holdings in LPL Financial Holdings Inc. $LPLA (source)
- LPL Financial Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call (source)
- Somesh Khanna Elected to LPL Financial Board of Directors (source)
- LPL Financial Welcomes Rand, Williams & Associates, LLC (source)
MDT (Medtronic plc.)
- 3 MedTech Stocks Benefiting From Favorable Product Mix Shifts (source)
- Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript (source)
- Medtronic has 'significant firepower' for multiple acquisitions, executives say (source)
- Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott (source)
SMMT (Summit Therapeutics Inc.)
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (source)
- Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference (source)
VTR (Ventas, Inc.)
- Oregon Public Employees Retirement Fund Raises Holdings in Ventas, Inc. $VTR (source)
- Ventas, Inc. (NYSE:VTR) Receives Consensus Rating of “Moderate Buy” from Analysts (source)
- Don't Be Fooled By These REITs In 2026 (source)
- Debra Cafaro Sells 10,322 Shares of Ventas (NYSE:VTR) Stock (source)
Market Context
Broad market indices showed modest declines on the session, with the Dow Jones posting the largest drop at -0.86%, followed by the S&P 500 at -0.20% and Nasdaq at -0.11%. This mildly bearish tone reflects a cautious risk appetite, where trend-following strategies like SMA20/SMA50 crossovers may face headwinds in confirming sustained directional moves. With 32 total signals generated, the strategy's reliance on smoother price action could be tested amid these subtle pullbacks, potentially leading to fewer high-conviction setups as short-term trends waver.
Rising VIX at 15.96 (+3.91%) signals increasing volatility, amplifying intraday swings that can whipsaw SMA crossovers—particularly the faster SMA20 reacting to noise while the SMA50 lags in choppier conditions. In this environment, signals may generate more false positives during heightened fluctuations, urging traders to prioritize confirmation from volume or higher timeframes to mitigate whipsaw risk. Overall, the elevated volatility tempers the strategy's edge in non-trending phases, favoring patience over aggressive entries.
Healthcare emerging as the top sector hints at defensive rotation amid broader weakness, where SMA20/SMA50 signals in resilient areas could outperform if trends stabilize. However, cross-market weakness and volatility suggest limited sector leadership, potentially diluting signal reliability outside defensive pockets and encouraging selective positioning aligned with rotation flows.
Vlad's Take (EverHint)
Today's signals: Strong sector concentration in Healthcare (8 signals) suggests sector-specific rotation. 2 signals with insider buying adds conviction. 9 signals showing insider selling warrant caution.
Sharing Call-to-Action
🌟 Help the channel grow: like, share, or subscribe if you find value in what EverHint publishes.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/